Cargando…
Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect
Rubinstein–Taybi syndrome (RSTS) is a rare dominant disorder with intellectual disability, postnatal growth deficiency, and multiple congenital anomalies. Approximately 50–70% of the patients have a mutation in the CREBBP gene (RSTS1) and 5–10% display an EP300 gene mutation (RSTS2). Craniospinal ab...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553355/ https://www.ncbi.nlm.nih.gov/pubmed/30789376 http://dx.doi.org/10.1097/MCD.0000000000000262 |
_version_ | 1783424800667992064 |
---|---|
author | Hadzsiev, Kinga Gyorsok, Zsuzsanna Till, Agnes Czakó, Márta Bartsch, Oliver |
author_facet | Hadzsiev, Kinga Gyorsok, Zsuzsanna Till, Agnes Czakó, Márta Bartsch, Oliver |
author_sort | Hadzsiev, Kinga |
collection | PubMed |
description | Rubinstein–Taybi syndrome (RSTS) is a rare dominant disorder with intellectual disability, postnatal growth deficiency, and multiple congenital anomalies. Approximately 50–70% of the patients have a mutation in the CREBBP gene (RSTS1) and 5–10% display an EP300 gene mutation (RSTS2). Craniospinal abnormalities such as microcranium, scoliosis, and lordosis are frequent findings in RSTS1, but malformations of the brain or spinal cord are seen only occasionally. Here, we report on a 3-year-old boy with facial abnormalities of RSTS, broad thumbs and halluces, developmental delay, autistic features, cerebellar underdevelopment, and a neural tube defect. Molecular diagnostic of the CREBBP and EP300 genes showed a heterozygous 17-bp deletion (c.5698_5714del AAGGCAGCAGGCCAGGT) in exon 31 of the EP300 gene. Findings underline that small (hypoplastic) cerebellum and neural tube defects belong to the phenotypic spectrum not only of RSTS1 but also of RSTS2. Based on the literature and this observation, we recommend that each individual with RSTS2 should be closely evaluated for neural axis and craniovertebral junction anomalies, and where appropriate, neuroimaging studies should be considered. Our frequency estimate of ~ 6% occult or overt neural tube defects in RSTS2 could represent an underestimate. |
format | Online Article Text |
id | pubmed-6553355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-65533552019-07-22 Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect Hadzsiev, Kinga Gyorsok, Zsuzsanna Till, Agnes Czakó, Márta Bartsch, Oliver Clin Dysmorphol Original Articles Rubinstein–Taybi syndrome (RSTS) is a rare dominant disorder with intellectual disability, postnatal growth deficiency, and multiple congenital anomalies. Approximately 50–70% of the patients have a mutation in the CREBBP gene (RSTS1) and 5–10% display an EP300 gene mutation (RSTS2). Craniospinal abnormalities such as microcranium, scoliosis, and lordosis are frequent findings in RSTS1, but malformations of the brain or spinal cord are seen only occasionally. Here, we report on a 3-year-old boy with facial abnormalities of RSTS, broad thumbs and halluces, developmental delay, autistic features, cerebellar underdevelopment, and a neural tube defect. Molecular diagnostic of the CREBBP and EP300 genes showed a heterozygous 17-bp deletion (c.5698_5714del AAGGCAGCAGGCCAGGT) in exon 31 of the EP300 gene. Findings underline that small (hypoplastic) cerebellum and neural tube defects belong to the phenotypic spectrum not only of RSTS1 but also of RSTS2. Based on the literature and this observation, we recommend that each individual with RSTS2 should be closely evaluated for neural axis and craniovertebral junction anomalies, and where appropriate, neuroimaging studies should be considered. Our frequency estimate of ~ 6% occult or overt neural tube defects in RSTS2 could represent an underestimate. Lippincott Williams & Wilkins 2019-07 2019-02-19 /pmc/articles/PMC6553355/ /pubmed/30789376 http://dx.doi.org/10.1097/MCD.0000000000000262 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Articles Hadzsiev, Kinga Gyorsok, Zsuzsanna Till, Agnes Czakó, Márta Bartsch, Oliver Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect |
title | Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect |
title_full | Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect |
title_fullStr | Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect |
title_full_unstemmed | Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect |
title_short | Rubinstein–Taybi syndrome 2 with cerebellar abnormality and neural tube defect |
title_sort | rubinstein–taybi syndrome 2 with cerebellar abnormality and neural tube defect |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553355/ https://www.ncbi.nlm.nih.gov/pubmed/30789376 http://dx.doi.org/10.1097/MCD.0000000000000262 |
work_keys_str_mv | AT hadzsievkinga rubinsteintaybisyndrome2withcerebellarabnormalityandneuraltubedefect AT gyorsokzsuzsanna rubinsteintaybisyndrome2withcerebellarabnormalityandneuraltubedefect AT tillagnes rubinsteintaybisyndrome2withcerebellarabnormalityandneuraltubedefect AT czakomarta rubinsteintaybisyndrome2withcerebellarabnormalityandneuraltubedefect AT bartscholiver rubinsteintaybisyndrome2withcerebellarabnormalityandneuraltubedefect |